Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cogent Biosciences, Inc. | Director | Stock Option (Right to Buy) | 44.7K | Jun 5, 2024 | Direct | ||
Viridian Therapeutics, Inc.\DE | Director | Stock Option (Right to Buy) | 21K | Jun 26, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics, Inc.\DE | Jun 26, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director |
COGT | Cogent Biosciences, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
VRDN | Viridian Therapeutics, Inc.\DE | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
COGT | Cogent Biosciences, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
VRDN | Viridian Therapeutics, Inc.\DE | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
COGT | Cogent Biosciences, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
VRDN | Viridian Therapeutics, Inc.\DE | Jun 3, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |